WO2006034468A8 - Procedes et compositions pour le traitement de troubles hyperglycemiques, hyperlipidemiques, ou hyperinsulinemiques - Google Patents

Procedes et compositions pour le traitement de troubles hyperglycemiques, hyperlipidemiques, ou hyperinsulinemiques

Info

Publication number
WO2006034468A8
WO2006034468A8 PCT/US2005/034225 US2005034225W WO2006034468A8 WO 2006034468 A8 WO2006034468 A8 WO 2006034468A8 US 2005034225 W US2005034225 W US 2005034225W WO 2006034468 A8 WO2006034468 A8 WO 2006034468A8
Authority
WO
WIPO (PCT)
Prior art keywords
disorders
compositions
hyperinsulinemic
hyperlipidemic
methods
Prior art date
Application number
PCT/US2005/034225
Other languages
English (en)
Other versions
WO2006034468A3 (fr
WO2006034468A9 (fr
WO2006034468A2 (fr
Inventor
Xiaozhuo Chen
Klaus Himmeldirk
Yulin Ren
Original Assignee
Univ Ohio
Xiaozhuo Chen
Klaus Himmeldirk
Yulin Ren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio, Xiaozhuo Chen, Klaus Himmeldirk, Yulin Ren filed Critical Univ Ohio
Priority to CA2581485A priority Critical patent/CA2581485C/fr
Priority to US11/575,938 priority patent/US7687472B2/en
Priority to GB0707437A priority patent/GB2433935B/en
Publication of WO2006034468A2 publication Critical patent/WO2006034468A2/fr
Publication of WO2006034468A3 publication Critical patent/WO2006034468A3/fr
Publication of WO2006034468A8 publication Critical patent/WO2006034468A8/fr
Publication of WO2006034468A9 publication Critical patent/WO2006034468A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

La présente invention a trait à des procédés de traitement de troubles hyperglycémiques, hyperlipidémiques, ou hyperinsulinémiques. L'invention a également trait à des compositions pour le traitement de tels troubles. Les compositions peuvent inclure des variants d'hexose et de pentose ayant des groupes fonctionnels acides et un substituant Y lié à la position six d'un hexose ou la position cinq du pentose.
PCT/US2005/034225 2004-09-23 2005-09-23 Procedes et compositions pour le traitement de troubles hyperglycemiques, hyperlipidemiques, ou hyperinsulinemiques WO2006034468A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA2581485A CA2581485C (fr) 2004-09-23 2005-09-23 Procedes et compositions pour le traitement de troubles hyperglycemiques, hyperlipidemiques, ou hyperinsulinemiques
US11/575,938 US7687472B2 (en) 2004-09-23 2005-09-23 Methods and compositions for treating hyperglycemic, hyperlipidemic, or hyperinsulinemic disorders
GB0707437A GB2433935B (en) 2004-09-23 2005-09-23 Compounds for treating diabetes and related disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61235404P 2004-09-23 2004-09-23
US60/612,354 2004-09-23

Publications (4)

Publication Number Publication Date
WO2006034468A2 WO2006034468A2 (fr) 2006-03-30
WO2006034468A3 WO2006034468A3 (fr) 2006-04-20
WO2006034468A8 true WO2006034468A8 (fr) 2006-05-18
WO2006034468A9 WO2006034468A9 (fr) 2006-07-27

Family

ID=36090702

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/034225 WO2006034468A2 (fr) 2004-09-23 2005-09-23 Procedes et compositions pour le traitement de troubles hyperglycemiques, hyperlipidemiques, ou hyperinsulinemiques

Country Status (4)

Country Link
US (1) US7687472B2 (fr)
CA (1) CA2581485C (fr)
GB (1) GB2433935B (fr)
WO (1) WO2006034468A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007518821A (ja) 2004-01-23 2007-07-12 オハイオ ユニバーシティー Ｐｇｇの分離および精製

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538987A (ja) * 2002-07-24 2005-12-22 オハイオ ユニバーシティー 真性糖尿病を処置するための方法および組成物
US20040258773A1 (en) * 2002-09-03 2004-12-23 Xiaozhuo Chen Composition and methods for treating subjects with hyperglycemia

Also Published As

Publication number Publication date
GB2433935A (en) 2007-07-11
CA2581485A1 (fr) 2006-03-30
US20070293439A1 (en) 2007-12-20
WO2006034468A3 (fr) 2006-04-20
GB0707437D0 (en) 2007-05-23
CA2581485C (fr) 2013-07-16
WO2006034468A9 (fr) 2006-07-27
GB2433935B (en) 2009-04-08
WO2006034468A2 (fr) 2006-03-30
US7687472B2 (en) 2010-03-30

Similar Documents

Publication Publication Date Title
WO2007106469A3 (fr) Derives bicycliques de l'acide carboxylique utiles dans le traitement de troubles metaboliques
WO2007136759A3 (fr) Procédé de traitement et de prévention de troubles oculaires
WO2006058648A3 (fr) Acides biaryloxymethylarenecarboxyliques
WO2006113942A3 (fr) Procede d'inhibition de l'activite de cathepsine
WO2006073940A3 (fr) Administration par voies multiples de composes modificateurs de reponse immunitaire
MX2007007174A (es) Derivados de cicloalquilamina.
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2008001195A3 (fr) Nouveaux procédés de synthèse d'inhibiteurs de dpp iv
WO2005028628A3 (fr) Modulation de l'expression de eif4e
WO2008070692A8 (fr) Composés chimiques et leurs utilisations
WO2006034154A3 (fr) Sels de 5-azacytidine
WO2006058628A3 (fr) Derives benzoquinolizine substitues
WO2005074607A3 (fr) Procede de traitement de maladies hemolytiques
WO2007059230A3 (fr) 1h-benzimidazole-4-carboxamides substitues efficaces en tant qu’inhibiteurs de parp
WO2007041130A3 (fr) Deazapurines convenant comme inhibiteurs des janus kinases
WO2006015159A3 (fr) Inhibiteurs de canal a potassium
WO2004062613A3 (fr) Inhibiteurs d'integrase hiv
WO2007092496A3 (fr) 7,9-dihydro-purin-8-one et analogues associés utilisés en tant qu'inhibiteurs de hsp90
WO2006105359A3 (fr) Methodes pour stimuler la pousse des cheveux par administration de proteines bmp
WO2008069889A3 (fr) Procédés permettant de traiter l'anémie hémolytique
WO2008048589A3 (fr) Composés et procédés pour le traitement du virus de l'hépatite c
DE60114468D1 (de) Optimierung der herstellung von polycarbonat durch umesterung
WO2007109279A3 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
WO2005004808A3 (fr) Composes tetracycliques utilises comme inhibiteurs de c-met
WO2009067493A3 (fr) Benzènes 1,3,5-trisubstitués pour le traitement de la maladie d'alzheimer et d'autres troubles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2581485

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 0707437

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20050923

WWE Wipo information: entry into national phase

Ref document number: 0707437.0

Country of ref document: GB

WWE Wipo information: entry into national phase

Ref document number: 11575938

Country of ref document: US

122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 11575938

Country of ref document: US